Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.
about
Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups.Chronic lymphocytic leukaemia genomics and the precision medicine era.Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in noNOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases.NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
P2860
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@en
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@nl
type
label
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@en
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@nl
prefLabel
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@en
Non-coding NOTCH1 mutations in ...... l impact in the UK CLL4 trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
Non-coding NOTCH1 mutations in ...... al impact in the UK CLL4 trial
@en
P2093
A J Steele
D Catovsky
D G Oscier
J C Strefford
L Kadalayil
P2860
P2888
P304
P356
10.1038/LEU.2016.298
P577
2016-10-26T00:00:00Z